Evidence map›Paper›PMID 41190332›Full record

ArticleImaging neuroscience (Cambridge, Mass.)2025

Semiparametric confidence sets for cross-sectional and longitudinal neuroimaging.

Xinyu Zhang, Kenneth Liao, Jakob Seidlitz, Maureen McHugo, Suzanne N Avery, Anna Huang, Aaron Alexander-Bloch, Neil Woodward, Stephan Heckers, Simon Vandekar

Abstract read
In one paragraph

Article in Imaging neuroscience (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Xinyu ZhangDepartment of Biostatistics, Vanderbilt University, Nashville, TN, United States.ORCID https://orcid.org/0009-0008-5545-8138
Kenneth LiaoDepartment of Biostatistics, Vanderbilt University, Nashville, TN, United States.
Jakob SeidlitzDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, United States.
Maureen McHugoDepartment of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Suzanne N AveryDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, United States.
Anna HuangDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, United States.
Aaron Alexander-BlochDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, United States.
Neil WoodwardDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, United States.
Stephan HeckersDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, United States.
Simon VandekarDepartment of Biostatistics, Vanderbilt University, Nashville, TN, United States.ORCID https://orcid.org/0000-0002-7457-9073

Funding

Imaging Hippocampal Function in PsychosisR01MH070560 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HECKERS, STEPHAN · 2005 to 2025
$7.2M
Precision brain charts for imaging-genomics of schizophrenia and the psychosis spectrumR01MH133843 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI Aaron Felix Alexander-Bloch · 2023 to 2026
$3.2M
Thalamocortical Networks in PsychosisR01MH102266 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WOODWARD, NEIL D. · 2014 to 2018
$2.3M
Semiparametric Inference for Psychiatric NeuroimagingR01MH123563 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI VANDEKAR, SIMON NEIL · 2020 to 2024
$2.1M
Research and mentoring on cognitive neuroscience and high-field MRI of the thalamus in schizophreniaK24MH126280 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WOODWARD, NEIL D. · 2021 to 2025
$747k
NIMH NIH HHS K24 MH126280NIMH NIH HHS R01 MH070560NIMH NIH HHS R01 MH102266NIMH NIH HHS R01 MH123563NIMH NIH HHS R01 MH133843
6 · The paper itself

Abstract

The majority of neuroimaging inference focuses on hypothesis testing rather than effect estimation. With concerns about replicability, there is growing interest in reporting standardized effect sizes from neuroimaging group-level analyses. Confidence sets for effect sizes were recently developed for neuroimaging, but are restricted to simple univariate contrasts (e.g., one-sample or two-sample test Cohen's d) and cross-sectional data. Thus, existing methods exclude increasingly common longitudinal associations of biological brain measurements with, potentially nonlinear, inter- and intra-individual variations in diagnosis, development, or symptoms. We use modern methods for confidence sets combined with a recently proposed robust effect size index to provide a very general approach and software for effect size confidence set inference in neuroimaging. Our method involves robust estimation of the effect size image and spatial and temporal covariance function based on generalized estimating equations. We use a nonparametric bootstrap to estimate the joint distribution of the robust effect size image across voxels to construct confidence sets. These confidence sets identify regions of the image where the lower or upper simultaneous confidence interval is above or below a given threshold with high probability. We evaluate the coverage and simultaneous confidence interval width of the proposed procedures using realistic simulations and perform longitudinal analyses of aging and diagnostic differences of cortical thickness in Alzheimer's disease and diagnostic differences of resting-state hippocampal activity in psychosis. This comprehensive approach, along with the visualization functions integrated into the pbj R package, offers a robust tool for analyzing repeated neuroimaging measurements.

Indexed as

bootstrapgeneralized estimating equationmulti-parameter analysisneuroimaging data

Identifiers

PMID41190332
PMCPMC12580815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.